4.7 Article

HIV-1 Subtype Is an Independent Predictor of Reverse Transcriptase Mutation K65R in HIV-1 Patients Treated with Combination Antiretroviral Therapy Including Tenofovir

Journal

ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
Volume 57, Issue 2, Pages 1053-1056

Publisher

AMER SOC MICROBIOLOGY
DOI: 10.1128/AAC.01668-12

Keywords

-

Funding

  1. European Community's Seventh Framework Programme (FP7) under the project Collaborative HIV and Anti-HIV Drug Resistance Network (CHAIN)
  2. FWO grant [G.0611.09]
  3. Interuniversity Attraction Poles Programme, Belgian State, Belgian Science Policy [IAP-VI P6/41]
  4. research fund (PDM) of the KU Leuven
  5. Fonds voor Wetenschappelijk Onderzoek (FWO) Flanders
  6. Fundacao para a Ciencia e Tecnologia [SFRH/BPD/65605/2009]
  7. Fundação para a Ciência e a Tecnologia [SFRH/BPD/65605/2009] Funding Source: FCT

Ask authors/readers for more resources

Subtype-dependent selection of HIV-1 reverse transcriptase resistance mutation K65R was previously observed in cell culture and small clinical investigations. We compared K65R prevalence across subtypes A, B, C, F, G, and CRF02_AG separately in a cohort of 3,076 patients on combination therapy including tenofovir. K65R selection was significantly higher in HIV-1 subtype C. This could not be explained by clinical and demographic factors in multivariate analysis, suggesting subtype sequence-specific K65R pathways.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.7
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available